Overview of contrast enhancement with iron oxides.

Suppr

超能文献

作者信息

Frija G, Clément O, de Kerviler E

机构信息

Laboratoire de Recherche en Imagerie, Paris, France.

出版信息

Invest Radiol. 1994 Jun;29 Suppl 2:S75-7. doi: 10.1097/00004424-199406001-00025.

DOI:10.1097/00004424-199406001-00025

PMID:7928276

Abstract

摘要

相似文献

Overview of contrast enhancement with iron oxides.

Invest Radiol. 1994 Jun;29 Suppl 2:S75-7. doi: 10.1097/00004424-199406001-00025.

Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.

Acad Radiol. 1996 Aug;3 Suppl 2:S299-300. doi: 10.1016/s1076-6332(96)80563-0.

[Overview of MRI contrast media. The case of endorem].

Radiologe. 1995 Nov;35(11 Suppl 2):S247-8.

Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver.

Acad Radiol. 2002 Aug;9 Suppl 2:S336-8. doi: 10.1016/s1076-6332(03)80222-2.

Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.

Invest Radiol. 1994 Jun;29 Suppl 2:S78-80. doi: 10.1097/00004424-199406001-00026.

MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.

Acad Radiol. 1998 Apr;5 Suppl 1:S170-2; discussion S183-4. doi: 10.1016/s1076-6332(98)80096-2.

Transferrin receptor expression in iron oxide-labeled mesenchymal stem cells.

Radiology. 2008 Jun;247(3):913; author reply 914-5. doi: 10.1148/radiol.2473071876.

Preliminary clinical experience with AMI 227.

Acad Radiol. 1996 Aug;3 Suppl 2:S295-6. doi: 10.1016/s1076-6332(96)80561-7.

Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.

Acad Radiol. 1996 Aug;3 Suppl 2:S409-12. doi: 10.1016/s1076-6332(96)80600-3.

[MR contrast agent: resovist (SH U 555A)].

Nihon Rinsho. 2001 Oct;59 Suppl 6:328-32.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Overview of contrast enhancement with iron oxides.

Invest Radiol. 1994 Jun;29 Suppl 2:S75-7. doi: 10.1097/00004424-199406001-00025.

Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.

Acad Radiol. 1996 Aug;3 Suppl 2:S299-300. doi: 10.1016/s1076-6332(96)80563-0.

[Overview of MRI contrast media. The case of endorem].

Radiologe. 1995 Nov;35(11 Suppl 2):S247-8.

Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver.

Acad Radiol. 2002 Aug;9 Suppl 2:S336-8. doi: 10.1016/s1076-6332(03)80222-2.

Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.

Invest Radiol. 1994 Jun;29 Suppl 2:S78-80. doi: 10.1097/00004424-199406001-00026.

MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.

Acad Radiol. 1998 Apr;5 Suppl 1:S170-2; discussion S183-4. doi: 10.1016/s1076-6332(98)80096-2.

Transferrin receptor expression in iron oxide-labeled mesenchymal stem cells.

Radiology. 2008 Jun;247(3):913; author reply 914-5. doi: 10.1148/radiol.2473071876.

Preliminary clinical experience with AMI 227.

Acad Radiol. 1996 Aug;3 Suppl 2:S295-6. doi: 10.1016/s1076-6332(96)80561-7.

Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.

Acad Radiol. 1996 Aug;3 Suppl 2:S409-12. doi: 10.1016/s1076-6332(96)80600-3.

[MR contrast agent: resovist (SH U 555A)].

Nihon Rinsho. 2001 Oct;59 Suppl 6:328-32.